Novacyt Sa Stock Price on August 14, 2024
NVYTF Stock | USD 0.63 0.02 3.28% |
If you're considering investing in Novacyt Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Novacyt SA stands at 0.63, as last reported on the 29th of December, with the highest price reaching 0.63 and the lowest price hitting 0.63 during the day. Novacyt SA has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12% return per unit of risk over the last 3 months. Novacyt SA exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novacyt SA's Risk Adjusted Performance of (0.08), mean deviation of 1.74, and Standard Deviation of 4.59 to check out the risk estimate we provide.
Novacyt Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Novacyt |
Sharpe Ratio = -0.1171
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NVYTF |
Estimated Market Risk
4.66 actual daily | 41 59% of assets are more volatile |
Expected Return
-0.55 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novacyt SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novacyt SA by adding Novacyt SA to a well-diversified portfolio.
Related Headline
BIOLASE Headline on 21st of June 2024
Global Medical Laser Systems Market Size To Worth USD 15.89 ... by finance.yahoo.com
The Global Medical Laser Systems Market Size was Valued at USD 4.6 Billion in 2023 and the Worldwide Medical Laser Systems Market Size is Expected to Reach USD 15.89 Billion by 2033, according to a research report published by Spherical Insights Consulting. Companies covered Lumenix, Photomedex, Philips Healthcare, BIOLASE, IRIDEX Corporation, BioForm Medical, biolitec AG, Cutera, Candela Corporation, Cynosure, Quantana Systems, Topcon Corporation, Boston Scientific Corporation, ZEISS Corpora
Novacyt SA Valuation on August 14, 2024
It is possible to determine the worth of Novacyt SA on a given historical date. On August 14, 2024 Novacyt was worth 0.54 at the beginning of the trading date compared to the closed value of 0.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novacyt SA pink sheet. Still, in general, we apply an absolute valuation method to find Novacyt SA's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novacyt SA where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novacyt SA's related companies.
Open | High | Low | Close | Volume | |
0.54 | 0.54 | 0.54 | 0.54 | 1.00 | |
08/14/2024 | 0.54 | 0.54 | 0.54 | 0.54 | 1.00 |
0.77 | 0.77 | 0.77 | 0.77 | 3,000 |
Backtest Novacyt SA | | | Novacyt SA History | | | Novacyt SA Valuation | Previous | Next |
Novacyt SA Trading Date Momentum on August 14, 2024
On August 15 2024 Novacyt SA was traded for 0.77 at the closing time. The highest daily price throughout the period was 0.77 and the lowest price was 0.77 . The daily volume was 3 K. The net trading volume on 08/15/2024 added to the next day price rise. The trading delta at closing time to closing price of the next trading day was 42.59% . The trading delta at closing time to current closing price is 131.48% . |
Novacyt SA Fundamentals Correlations and Trends
By evaluating Novacyt SA's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novacyt SA's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novacyt financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novacyt SA Pink Sheet history
Novacyt SA investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novacyt is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novacyt SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novacyt SA stock prices may prove useful in developing a viable investing in Novacyt SA
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Vlizy-Villacoublay, France. Novacyt operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 210 people.
Novacyt SA Pink Sheet Technical Analysis
Novacyt SA technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Novacyt SA Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Novacyt SA cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Novacyt SA December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Novacyt SA pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novacyt SA shares will generate the highest return on investment. By undertsting and applying Novacyt SA pink sheet market strength indicators, traders can identify Novacyt SA entry and exit signals to maximize returns
Novacyt SA Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novacyt SA's price direction in advance. Along with the technical and fundamental analysis of Novacyt Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novacyt to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.51) | |||
Total Risk Alpha | (0.67) | |||
Treynor Ratio | 0.489 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Novacyt Pink Sheet analysis
When running Novacyt SA's price analysis, check to measure Novacyt SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novacyt SA is operating at the current time. Most of Novacyt SA's value examination focuses on studying past and present price action to predict the probability of Novacyt SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novacyt SA's price. Additionally, you may evaluate how the addition of Novacyt SA to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |